Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > フローサイトメトリー抗体

Anti-Human IL‑23 p19 Recombinant Antibody (SAA0392) (HV466207)

Anti-Human IL‑23 p19 Recombinant Antibody (SAA0392)
Anti-Human IL‑23 p19 Recombinant Antibody (SAA0392)
Anti-Human IL‑23 p19 Recombinant Antibody (SAA0392)
Anti-Human IL‑23 p19 Recombinant Antibody (SAA0392)
Anti-Human IL‑23 p19 Recombinant Antibody (SAA0392)
Anti-Human IL‑23 p19 Recombinant Antibody (SAA0392)
価格(USD):
スペック:
  • 50ug
  • 100ug
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号HV466207
種反応性Human
アプリケーションELISA, FCM, WB
宿主種Human
クローン性Monoclonal
アイソタイプIgG4, kappa
クローンIDSAA0392
テスト済みアプリケーション WB, FCM
ターゲット IL-23 subunit alpha, IL-23-A, IL-23p19, IL23A, Interleukin-23 subunit alpha, Interleukin-23 subunit p19, SGRF
エンドトキシンレベル < 10 EU/mg
純度 >95% as determined by SDS-PAGE.
精製 Protein A/G purified from cell culture supernatant.
アクセッション番号 Q9NPF7
形態 Liquid
保存バッファー 0.01M PBS pH 7.4.

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

安定性と保存 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
背景

Interleukin-23 subunit alpha (IL23A) is a ~20 kDa protein. Associates with IL12B to form the pro-inflammatory cytokine IL-23 that plays different roles in innate and adaptive immunity. Released by antigen-presenting cells such as dendritic cells or macrophages, binds to a heterodimeric receptor complex composed of IL12RB1 and IL23R to activate JAK2 and TYK2 which then phosphorylate the receptor to form a docking site leading to the phosphorylation of STAT3 and STAT4. This process leads to activation of several pathways including p38 MAPK or NF-kappa-B and promotes the production of pro-inflammatory cytokines such as interleukin-17A/IL17A. In turn, participates in the early and effective intracellular bacterial clearance. Promotes the expansion and survival of T-helper 17 cells, a CD4-positive helper T-cell subset that produces IL-17, as well as other IL-17-producing cells. IL23A is the therapeutic target of guselkumab (Tremfya).

1. Oppmann, B. et al. (2000) Immunity 13, 715-25. PMID: 11114383
2. Bloch, Y. et al. (2018) Immunity 48, 45-58.e6. PMID: 29287995
3. Sun, R. et al. (2020) Cellular and molecular gastroenterology and hepatology 10, 673-697. PMID: 32474165
4. Glassman, CR. et al. (2021) Cell 184, 983-999.e24. PMID: 33606986
5. Parham, C. et al. (2002) Journal of immunology (Baltimore, Md. : 1950) 168, 5699-708. PMID: 12023369
6. Wilson, NJ. et al. (2007) Nature immunology 8, 950-7. PMID: 17676044
注意事項 For research use only.
イメージ
  • Anti-Human IL‑23 p19 Recombinant Antibody (SAA0392)

    Bioactivity

    SEC-HPLC detection for Anti-Human IL23A Antibody (ABS0131).

  • Anti-Human IL‑23 p19 Recombinant Antibody (SAA0392)

    Flow Cytometry

    Flow-cytometry using anti-human IL23A antibody.IL23A Transfected CHO cells were stained with an irrelevant antibody (Blue Histogram) or an anti-human IL23A antibody monoclonal antibody (Catalog # HV466207 ,Green Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a FITC conjugated goat anti-human antibody (Catalog # HF690414) and cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human IL‑23 p19 Recombinant Antibody (SAA0392)

    Western blot

    Western blot analysis was performed using anti-IL23A monoclonal antibody at 1ug/mL on various samples.
    Lane 1: recombinant human IL23A (Catalog No: HV466011)
    Lane 2: negative control

参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト